Effects of capecitabine as part of neo-/adjuvant chemotherapy – A meta-analysis of individual breast cancer patient data from 13 randomised trials including 15,993 patients-Reference-Cited by-同舟云学术

Effects of capecitabine as part of neo-/adjuvant chemotherapy – A meta-analysis of individual breast cancer patient data from 13 randomised trials including 15,993 patients

Published:2022-05 Issue: Volume:166 Page:185-201
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

van Mackelenbergh Marion T.,Seither Fenja,Möbus Volker,O'Shaughnessy Joyce,Martin Miguel,Joensuu Heikki,Untch Michael,Nitz Ulrike,Steger Guenther G.,Miralles Juan J.^ORCID,Barrios Carlos H.^ORCID,Toi Masakazu^ORCID,Bear Harry D.^ORCID,Muss Hyman,Reimer Toralf,Nekljudova Valentina,Loibl Sibylle^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Capecitabine: a review;Walko;Clin Ther,2005

2. Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study;von Minckwitz;J Clin Oncol. official journal of the American Society of Clinical Oncology.,2010

3. A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52);von Minckwitz;Cancer,2015

4. Phase III trial of adjuvant capecitabine after standard neo-/adjuvant chemotherapy in patients with early triple-negative breast cancer (GEICAM/2003-11_CIBOMA/2004-01);Lluch;J Clin Oncol,2020

5. Adjuvant capecitabine in combination with docetaxel, epirubicin, and cyclophosphamide for early breast cancer: the randomized clinical FinXX trial;Joensuu;JAMA Oncol,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 47/w mit größenprogredienter Raumforderung der linken Brust;Die Gynäkologie;2024-05-28

2. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer;ESMO Open;2024-05

3. Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer;Revista Brasileira de Ginecologia e Obstetrícia;2024

4. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†;Annals of Oncology;2023-12

5. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023;Annals of Oncology;2023-11